Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis - PubMed (original) (raw)
. 2004 Nov 18;23(54):8841-6.
doi: 10.1038/sj.onc.1208137.
Affiliations
- PMID: 15480421
- DOI: 10.1038/sj.onc.1208137
Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis
Krisanee Chalitchagorn et al. Oncogene. 2004.
Abstract
Genome-wide losses of DNA methylation have been regarded as a common epigenetic event in malignancies and may play crucial roles in carcinogenesis. Limited information is available on the global methylation status in normal tissues and other cancer types beyond colonic carcinoma. Here we applied the combined bisulfite restriction analysis PCR to evaluate the methylation status of LINE-1 repetitive sequences in genomic DNA derived from microdissected samples from several human normal and neoplastic tissues. We found that methylation of LINE-1 in leukocytes was independent of age and gender. In contrast, normal tissues from different organs showed tissue-specific levels of methylated LINE-1. Globally, most carcinomas including breast, colon, lung, head and neck, bladder, esophagus, liver, prostate, and stomach, revealed a greater percentage of hypomethylation than their normal tissue counterparts. Furthermore, DNA derived from sera of patients with carcinoma displayed more LINE-1 hypomethylation than those of noncarcinoma individuals. Finally, in a colonic carcinogenesis model, we detected significantly greater hypomethylation in carcinoma than those of dysplastic polyp and histological normal colonic epithelium. Thus, the methylation status is a unique feature of a specific tissue type and the global hypomethylation is a common epigenetic process in cancer, which may progressively evolve during multistage carcinogenesis.
Similar articles
- Specific hypermethylation of LINE-1 elements during abnormal overgrowth and differentiation of human placenta.
Perrin D, Ballestar E, Fraga MF, Frappart L, Esteller M, Guerin JF, Dante R. Perrin D, et al. Oncogene. 2007 Apr 12;26(17):2518-24. doi: 10.1038/sj.onc.1210039. Epub 2006 Oct 9. Oncogene. 2007. PMID: 17043645 - DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas.
Florl AR, Löwer R, Schmitz-Dräger BJ, Schulz WA. Florl AR, et al. Br J Cancer. 1999 Jul;80(9):1312-21. doi: 10.1038/sj.bjc.6690524. Br J Cancer. 1999. PMID: 10424731 Free PMC article. - Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
Tangkijvanich P, Hourpai N, Rattanatanyong P, Wisedopas N, Mahachai V, Mutirangura A. Tangkijvanich P, et al. Clin Chim Acta. 2007 Apr;379(1-2):127-33. doi: 10.1016/j.cca.2006.12.029. Epub 2007 Jan 19. Clin Chim Acta. 2007. PMID: 17303099 - Is there a link between genome-wide hypomethylation in blood and cancer risk?
Brennan K, Flanagan JM. Brennan K, et al. Cancer Prev Res (Phila). 2012 Dec;5(12):1345-57. doi: 10.1158/1940-6207.CAPR-12-0316. Epub 2012 Nov 7. Cancer Prev Res (Phila). 2012. PMID: 23135621 Review. - LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis.
Barchitta M, Quattrocchi A, Maugeri A, Vinciguerra M, Agodi A. Barchitta M, et al. PLoS One. 2014 Oct 2;9(10):e109478. doi: 10.1371/journal.pone.0109478. eCollection 2014. PLoS One. 2014. PMID: 25275447 Free PMC article. Review.
Cited by
- Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study.
Gao Y, Baccarelli A, Shu XO, Ji BT, Yu K, Tarantini L, Yang G, Li HL, Hou L, Rothman N, Zheng W, Gao YT, Chow WH. Gao Y, et al. Br J Cancer. 2012 Jan 31;106(3):585-91. doi: 10.1038/bjc.2011.562. Epub 2011 Dec 15. Br J Cancer. 2012. PMID: 22173668 Free PMC article. - Methods for genome-wide analysis of DNA methylation in intestinal tumors.
Hahn MA, Pfeifer GP. Hahn MA, et al. Mutat Res. 2010 Nov 10;693(1-2):77-83. doi: 10.1016/j.mrfmmm.2009.10.005. Epub 2009 Oct 23. Mutat Res. 2010. PMID: 19854208 Free PMC article. Review. - Implications of LINE1 methylation for bladder cancer risk in women.
Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, Karagas MR, Marsit CJ. Wilhelm CS, et al. Clin Cancer Res. 2010 Mar 1;16(5):1682-9. doi: 10.1158/1078-0432.CCR-09-2983. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179218 Free PMC article. - Differential LINE-1 Hypomethylation of Gastric Low-Grade Dysplasia from High Grade Dysplasia and Intramucosal Cancer.
Lee JR, Chung WC, Kim JD, Lee KM, Paik CN, Jung SH, Jung JH, Lee YK, Han SW. Lee JR, et al. Gut Liver. 2011 Jun;5(2):149-53. doi: 10.5009/gnl.2011.5.2.149. Epub 2011 Jun 24. Gut Liver. 2011. PMID: 21814593 Free PMC article. - Adaptive evolution among cytoplasmic piRNA proteins leads to decreased genomic auto-immunity.
Wang L, Barbash DA, Kelleher ES. Wang L, et al. PLoS Genet. 2020 Jun 11;16(6):e1008861. doi: 10.1371/journal.pgen.1008861. eCollection 2020 Jun. PLoS Genet. 2020. PMID: 32525870 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources